Abstract
Genetics contributes to the risk of breast and ovarian cancer to a variable degree Rare families show dramatic clustering of breast and ovarian cancer, with cancers occurring at an early age.1 Most such families carry genetic alterations (or mutations) conferring an inherited predisposition to cancer. These families are often referred to as cancer-prone or high risk families; women from these families, if they inherit the cancer predisposition, may face a lifetime probability of cancer as high as 85–90%.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 1995;72:805–812
Yang Q, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD. Family history score as a predictor of breast mortality: prospective data from the cancer prevention study II, United States, 1982–1991. Am J Epidem 147:652–659, 1998
Wellisch DK, Gritz ER, Schain W, et al: Psychological functioning of daughters of breast cancer patients. Part 1: Daughters and comparison subjects. Psychomatics 32:324–336, 1991
Alexander NE, Ross J, Sumner W, Nease RF, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92–97, 1995
Gallup Survey 1995, cited in Mortality vital statistics report, Medical Tribune, Jan 25, p 17, 1996
Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics 1996. CA Cancer J Clin 46:5–27, 1996
Ferrar S. The anguished politics of breast cancer. NY Times Magazine 1993; Aug 15:24–27, 58-61
Shannon J: Portraints of breast cancer. Woman’s Day 1993; Oct 21:85, 88–90, 94,95
Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, et al: Family history, age, and risk of breast cancer. JAMA 270:338–343, 1993
Slattery ML, Kerber RA: A comprehensive evaluation of family history and breast cancer risk: the Utah population database. JAMA 270:1563–1568, 1993
Pharoah PDP, Day NE, et al: Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 71:800–809,1997
Claus EB, Risch N, Thompson WB: Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer 73:643–651, 1994
Kerber RA, Slattery ML: The impact of family history on ovarian cancer risk: the Utah population database. Arch Intern Med 155:905–912, 1995
Easton DF, Mathews FE, Ford D, Swerdlow AJ, Peto J: Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 65:284–294, 1996
Auranem A, Pukkala E, Makinen J, Samkila R, Grenman S, Salmi T: Cancer incidence in the first-degree relatives of ovarian cancer patients. Brit J Cancer 74:280–284, 1996
Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415, 1997
Shattuck-Eidens D, Oliphant A, McClure M, et al: BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 278:1242–1250, 1997
Wellisch DK, Gritz ER, Schain W, et al: Psychological functioning of daughters of breast cancer patients. Part 1: Daughters and comparison subjects. Psychomatics 32:324–336, 1991
Ford D, Eastin DF, Stratton M, et al: Genetic heterogeity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689, 1998
Easton DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q 12–13. Amer J Hum Genei 61:120–128, 1997
Rubin SC, Blackwood MA, Bandera C, et al: BRCA1, BRCA2 and hereditary non-polyposis col-orectal cancer gene mutations in an unselected ovarian cancer population: relationship to family hisotry and implications for genetic testing. Am J Ob Gynecol 178:670–677, 1998
Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685, 1993
Sidransky D, Tokino T, Helzlsouer K, et al: Inherited p53 gene mutations in breast cancer. Cancer Res 52:2984–2986, 1992
Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990
Liaw D, Marsh DJ, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 16:64–67, 1997
Malone KE, Daling JR, Thompson JD, et al: BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922–929, 1998
Newman B, Mu H, Butler LM, et al: Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915–921, 1998
Kerber RA, Slattery ML: Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidem 146:244–248, 1997
Parent M-E, Ghadrian PV, Lacroix A, Perret C: The reliability of recollections of family history: implications for the medical provider. J Cancer Ed 12:114–120, 1997
Burke W, Press N, Pinsky L: Breast carcinoma genetics from a primary care perspective. Cancer 80(Suppl):621–626, 1997
Szabo C, King M-C: Population Genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020, 1997
Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast ovarian cancer families. Am J Hum Genet 56:254–264, 1995
Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408, 1997
Whittemore AS, Gong G, Itnyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60:496–504, 1997
Thorlacius S, Olafsdottir G, Tryggvadottir L, et al: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117–119, 1996
Thorlacius S, Sigurdsson S, Bjarnadottir H, et al: Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079–1084, 1997
Roa BB, Boyd AA, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187, 1996
Levy-Lahad E, Catane R, Eisenberg S, et al: Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059–1067, 1997
Richards CS, Ward PA, Roa BB, et al: Screening for 185delAG in the Ashkenazim. Am J Hum Genet 60:1085–1098, 1997
Abeliovich D, Kaduri L, Lerer I, et al: The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505–514, 1997
Li FP, Fraumeni JF, Jr, Mulvihill JJ, et al: A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362, 1988
Frebourg T, Barbier N, Yan YX, et al: Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56:608–615, 1995
Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114–1125, 1995
Aarnio M, Mecklin J-P, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ, Willett WC: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 64:430–433, 1995
Rhyu MS: Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88:240–251, 1996
Watson P, Vasen HFA, Mecklin JD, et al: The risk of endometrial cancer in hereditary on polyposis colorectal cancer. Am J Med 96:516–520, 1994
D’Errico A, Taioli E, Chen X, Vineis P: Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1:149–173, 1996
Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 277:997–1003, 1997
Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a history of breast cancer. N Eng J Med 340(2):77–84, 1999
Struewing JP, et al: Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monograph 17:33–35, 1995
Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Natl Cancer Inst 90(18):1371–1388, 1998
Burke W, Petersen G, Lynch P, Daly M, Garber JE, Botkin J, Kahn MJE, McTiernan A, Offit K, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary nonpolyposis colon cancer JAMA 277:915–919, 1997
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burke, W. (1999). Genetics of Breast and Ovarian Cancer. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4699-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7128-1
Online ISBN: 978-1-4615-4699-3
eBook Packages: Springer Book Archive